Association between the risk of hypertension and triglyceride glucose index in Chinese regions: a systematic review and dose-response meta-analysis of a regional update
暂无分享,去创建一个
Jiaqi Zhang | Zhi-Da Shen | Qiuyu Jin | Qiang Fu | An-ran Xu
[1] Liu Yang,et al. Predicting hypertension by obesity- and lipid-related indices in mid-aged and elderly Chinese: a nationwide cohort study from the China Health and Retirement Longitudinal Study , 2023, BMC Cardiovascular Disorders.
[2] Chao-lei Chen,et al. Association between triglyceride glucose‐body mass index and hypertension in Chinese adults: A cross‐sectional study , 2023, Journal of clinical hypertension.
[3] Fan Luo,et al. Positive association of triglyceride-glucose index with new-onset hypertension among adults: a national cohort study in China , 2023, Cardiovascular Diabetology.
[4] Isao Usui. Common metabolic features of hypertension and type 2 diabetes , 2023, Hypertension Research.
[5] Qi-gui Liu,et al. Association of triglyceride-glucose index with incident hypertension among non-overweight healthy adults: A cohort study in China. , 2023, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[6] Yisi Wang,et al. The Increased Risk of Hypertension Caused by Irrational Dietary Pattern May Be Associated with Th17 Cell in the Middle-Aged and Elderly Rural Residents of Beijing City, Northern China: A 1:1 Matched Case-Control Study , 2023, Nutrients.
[7] M. Zhang,et al. Association of triglyceride-glucose index and its 6-year change with risk of hypertension: A prospective cohort study. , 2022, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[8] Jing Dong,et al. Association between surrogate indicators of insulin resistance and risk of type 2 diabetes combined with hypertension among Chinese adults: two independent cohort studies , 2022, Nutrition & Metabolism.
[9] Elham Shams,et al. Mechanisms and pharmacotherapy of hypertension associated with type 2 diabetes. , 2022, Biochemical pharmacology.
[10] Wenke Cheng,et al. Comparison of the predictive value of four insulin resistance surrogates for the prevalence of hypertension: a population-based study , 2022, Diabetology & Metabolic Syndrome.
[11] S. Li,et al. Associations of the Triglyceride and Glucose Index With Hypertension Stages, Phenotypes, and Their Progressions Among Middle-Aged and Older Chinese , 2022, International Journal of Public Health.
[12] F. Lu,et al. Associations between triglyceride-glucose index and different hypertension subtypes: A population-based study in China , 2022, Frontiers in Cardiovascular Medicine.
[13] Lei Cao,et al. Triglyceride-Glucose Index for the Diagnosis of Metabolic Syndrome: A Cross-Sectional Study of 298,652 Individuals Receiving a Health Check-Up in China , 2022, International journal of endocrinology.
[14] Jian‐Jun Li,et al. Landscape of cardiometabolic risk factors in Chinese population: a narrative review , 2022, Cardiovascular Diabetology.
[15] Xin Zhang,et al. Correlation between non‐insulin‐based insulin resistance indexes and the risk of prehypertension: A cross‐sectional study , 2022, Journal of clinical hypertension.
[16] P. López-Jaramillo,et al. Hypertension Pharmacological Treatment in Adults: A World Health Organization Guideline Executive Summary , 2021, Hypertension.
[17] J. Sowers,et al. Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease , 2021, Hypertension.
[18] G. Úrrutia,et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. , 2021, Revista espanola de cardiologia.
[19] N. Bello,et al. Hypertension in Women Across the Lifespan , 2021, Current Atherosclerosis Reports.
[20] Mihran V. Naljayan,et al. Hypertension, Obesity, and COVID-19: a Collision of Pandemics , 2021, Current Hypertension Reports.
[21] W. Yang,et al. Association Between Triglyceride-Glucose Index and Hypertension: A Meta-Analysis , 2021, Frontiers in Cardiovascular Medicine.
[22] M. Ezzati,et al. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension , 2021, Nature Reviews Cardiology.
[23] Meizi Cui,et al. Triglyceride–glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies , 2021, Cardiovascular Diabetology.
[24] D. Prabhakaran,et al. Hypertension in Low- and Middle-Income Countries. , 2021, Circulation research.
[25] J. J. González-Henríquez,et al. Resting metabolic rate is increased in hypertensive patients with overweight or obesity: Potential mechanisms , 2021, Scandinavian journal of medicine & science in sports.
[26] N. Cheng,et al. [Prospective cohort study of relationship of triglyceride, fasting blood-glucose and triglyceride glucose product index with risk of hypertension]. , 2021, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.
[27] Zhigang Guo,et al. The association of triglyceride and glucose index, and triglyceride to high‐density lipoprotein cholesterol ratio with prehypertension and hypertension in normoglycemic subjects: A large cross‐sectional population study , 2021, Journal of clinical hypertension.
[28] K. Kario,et al. Assessment of preferred methods to measure insulin resistance in Asian patients with hypertension , 2021, Journal of clinical hypertension.
[29] E. Mayo-Wilson,et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2020, BMJ.
[30] Dorairaj Prabhakaran,et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. , 2020, Hypertension.
[31] Xuan Li,et al. Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited. , 2020, The Canadian journal of cardiology.
[32] Weiqing Wang,et al. A high triglyceride glucose index is more closely associated with hypertension than lipid or glycemic parameters in elderly individuals: a cross-sectional survey from the Reaction Study , 2020, Cardiovascular Diabetology.
[33] Jiang He,et al. The global epidemiology of hypertension , 2020, Nature Reviews Nephrology.
[34] Xin Xu,et al. Metformin use and prostate cancer risk , 2019, Medicine.
[35] S. Khan,et al. Metabolic clustering of risk factors: evaluation of Triglyceride-glucose index (TyG index) for evaluation of insulin resistance , 2018, Diabetology & Metabolic Syndrome.
[36] L. Chuang,et al. Subclinical and overt hypothyroidism is associated with reduced glomerular filtration rate and proteinuria: a large cross-sectional population study , 2018, Scientific Reports.
[37] Rongjiong Zheng,et al. Triglyceride and glucose (TyG) index as a predictor of incident hypertension: a 9-year longitudinal population-based study , 2017, Lipids in Health and Disease.
[38] Song Jian,et al. Association and interaction between triglyceride–glucose index and obesity on risk of hypertension in middle-aged and elderly adults , 2017, Clinical and experimental hypertension.
[39] Zhengjing Huang,et al. Burden of hypertension in China: A nationally representative survey of 174,621 adults. , 2017, International journal of cardiology.
[40] D. Hipgrave,et al. Salt and Sodium Intake in China. , 2016, JAMA.
[41] P. Marik,et al. Narrative Review , 2012, Journal of intensive care medicine.
[42] M. Wofford,et al. Hypertension in Postmenopausal Women , 2012, Current Hypertension Reports.
[43] A. Stang. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses , 2010, European Journal of Epidemiology.
[44] M. Rodríguez-Moran,et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. , 2010, The Journal of clinical endocrinology and metabolism.
[45] Alex J Sutton,et al. Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. , 2008, Journal of clinical epidemiology.
[46] G. Guyatt,et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.
[47] F. Schmidt. Meta-Analysis , 2008 .
[48] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[49] P. Lefèbvre. The metabolic syndrome revisited , 2003 .
[50] S. Thompson,et al. Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.
[51] I. Olkin,et al. Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .
[52] G. Smith,et al. Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.
[53] S. Leeder,et al. A population based study , 1993, The Medical journal of Australia.
[54] Pedagógia,et al. Cross Sectional Study , 2019 .
[55] S. Morton,et al. A Proposal for Reporting , 2010 .
[56] V. Preedy,et al. Prospective Cohort Study , 2010 .
[57] H. Min. A 1:1 Matched Case-control Study on the Risk Factors for Inguinal Hernia in Children , 2008 .
[58] I. Olkin,et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. , 2000, JAMA.
[59] R. Walker. β ℕ Revisited , 1974 .